Understanding the Burden of Primary Hyperoxaluria Type 1 (PH1)

A Survey of Physician Experiences with PH1

Alnylam wanted to better characterize PH1 natural history in terms of clinical manifestations, interventions, and resource use events that contribute to disease burden throughout the patent journey. This one-pager breaks down the key findings from this important research.